• #Imagine
  • Pharmaceutical Market | Facts & Figures

    Pharmaceutical Market | Facts & Figures

  • "proSfEEroume"

  • #WeWontRest
  • Revision of the EU Pharmaceutical Legislation

    Revision of the EU Pharmaceutical Legislation

  • Disease-specific groups

    Disease-specific groups

  • We invest in pharmaceutical innovation in Greece and in E.U.

    We invest in pharmaceutical innovation in Greece and in E.U.

WHO WE ARE

WHO WE ARE

The Hellenic Association of Pharmaceutical Companies (SFEE) represents one of the most innovative, productive and extroverted industries of the national economy.

The aim of SFEE is to contribute to the establishment of a sustainable human-centered healthcare system that promotes public health and allows pharmaceutical companies to innovate, research, develop and offer new innovative and established treatment options for Greek patients, while contributing to the development of the national economy.

CONTRIBUTION

  • SOCIETY

    SOCIETY

    Corporate Social Responsibility (CSR) is an essential element in all aspects of the strategy and day-to-day operations of SFEE. We are always on the side of society and patients, actively contributing to the support of our fellow citizens in need.

  • ECONOMY

    ECONOMY

    By prioritizing continuous investment, promoting clinical research, introducing research know-how and creating new jobs, we contribute to the strengthening of business activity and the development of the national economy.

  • RESEARCH & DEVELOPMENT

    RESEARCH & DEVELOPMENT

    We enhance the development of clinical research, by highlighting its role in improving the lives of patients and saving resources for the National Health System, as well as its essential contribution to the development of the national economy. Our goal is to make Greece a strong center for clinical studies with international impact.

THE GREEK PHARMACEUTICAL INDUSTRY IN FIGURES

€6,5 billion

€6,5 billion

the overall contribution to the economy

3,2%

3,2%

the contribution to GDP

€1,8 billion

€1,8 billion

the impact on tax revenue

118,900

118,900

the overall contribution to employment

38%

38%

of the medicines on the market are the result of collaborations between Greek & international companies

FFF Image

LATEST NEWS

PHARMACEUTICAL LEGISLATION

Search here for the pharmaceutical legislation in force and historical legislative references, as edited by the legal department of SFEE.

PHARMACEUTICAL LEGISLATION
HELPDESK

HELPDESK

PHARMACEUTICAL LEGISLATION

Register a new request or follow the progress of your request.

FFF Image

TRANSPARENCY

Skip to content